$557 Million is the total value of Davide Leone & Partners Investment Co Ltd.'s 12 reported holdings in Q3 2019. The portfolio turnover from Q2 2019 to Q3 2019 was 73.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| AABA | Buy | ALTABA INC | $106,092,000 | -63.7% | 5,446,180 | +29.4% | 19.05% | -19.0% |
| CELG | CELGENE CORP | $100,094,000 | +7.4% | 1,008,000 | 0.0% | 17.97% | +139.4% | |
| T | Sell | AT&T INC | $85,380,000 | +11.0% | 2,256,331 | -1.7% | 15.33% | +147.4% |
| BB | BLACKBERRY LTD | $56,279,000 | -29.6% | 10,719,892 | 0.0% | 10.10% | +56.8% | |
| Sell | ILLUMINA INCnote 0.500% 6/1 | $49,155,000 | -20.5% | 36,961,000 | -7.5% | 8.83% | +77.2% | |
| ZAYO | Sell | ZAYO GROUP HLDGS INC | $46,299,000 | -45.2% | 1,365,744 | -46.8% | 8.31% | +22.1% |
| S | New | SPRINT CORPORATION | $38,690,000 | – | 6,270,634 | +100.0% | 6.95% | – |
| BIIB | New | BIOGEN INC | $32,387,000 | – | 139,107 | +100.0% | 5.82% | – |
| INCY | Sell | INCYTE CORP | $27,717,000 | -55.3% | 373,387 | -48.8% | 4.98% | -0.4% |
| VRTX | New | VERTEX PHARMACEUTICALS INC | $12,970,000 | – | 76,558 | +100.0% | 2.33% | – |
| New | AVAYA HLDGS CORPnote 2.250% 6/1 | $1,542,000 | – | 1,800,000 | +100.0% | 0.28% | – | |
| BRKA | BERKSHIRE HATHAWAY INC DELcl a | $312,000 | -1.9% | 1 | 0.0% | 0.06% | +115.4% | |
| RHT | Exit | RED HAT INC | $0 | – | -6,601 | -100.0% | -0.10% | – |
| LGFB | Exit | LIONS GATE ENTMNT CORPcl b non vtg | $0 | – | -156,483 | -100.0% | -0.15% | – |
| LGFA | Exit | LIONS GATE ENTMNT CORPcl a vtg | $0 | – | -1,109,178 | -100.0% | -1.10% | – |
| NLSN | Exit | NIELSEN HLDGS PLC | $0 | – | -1,203,370 | -100.0% | -2.19% | – |
| ARRY | Exit | ARRAY BIOPHARMA INC | $0 | – | -1,817,309 | -100.0% | -6.78% | – |
| APC | Exit | ANADARKO PETE CORP | $0 | – | -1,600,773 | -100.0% | -9.10% | – |
| BABA | Exit | ALIBABA GROUP HLDG LTDput | $0 | – | -1,472,600 | -100.0% | -20.10% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BERKSHIRE HATHAWAY INC DEL | 19 | Q3 2023 | 7.8% |
| ACADIA HEALTHCARE COMPANY IN | 9 | Q4 2021 | 14.1% |
| BLACKBERRY LTD | 9 | Q4 2021 | 10.1% |
| ILLUMINA INC | 8 | Q4 2020 | 8.8% |
| ENCOMPASS HEALTH CORP | 7 | Q2 2022 | 98.2% |
| INCYTE CORP | 6 | Q1 2021 | 5.0% |
| AMERICAN WELL CORP | 6 | Q4 2021 | 2.7% |
| BIOMARIN PHARMACEUTICAL INC | 5 | Q3 2021 | 9.1% |
| VONTIER CORPORATION | 5 | Q4 2021 | 9.9% |
| QIAGEN NV | 5 | Q1 2021 | 7.7% |
View Davide Leone & Partners Investment Co Ltd.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| 13F-HR/A | 2021-11-16 |
View Davide Leone & Partners Investment Co Ltd.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.